Orbimed Advisors LLC Pmv Pharmaceuticals, Inc. Transaction History
Orbimed Advisors LLC
- $4.15 Billion
- Q2 2024
A detailed history of Orbimed Advisors LLC transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 6,475,291 shares of PMVP stock, worth $9.71 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
6,475,291
Previous 6,475,291
-0.0%
Holding current value
$9.71 Million
Previous $11 Million
4.71%
% of portfolio
0.25%
Previous 0.25%
Shares
4 transactions
Others Institutions Holding PMVP
# of Institutions
101Shares Held
43.4MCall Options Held
500Put Options Held
100-
Arrow Mark Colorado Holdings LLC Denver, CO2.8MShares$4.21 Million0.06% of portfolio
-
Sio Capital Management, LLC New York, NY2.71MShares$4.06 Million1.64% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$3.94 Million0.54% of portfolio
-
Alkeon Capital Management LLC New York, NY2.35MShares$3.52 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$3.42 Million0.0% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $68.4M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...